The latest closing stock price for Brainstorm Cell Therapeutics as of February 21, 2025 is 1.73.
An investor who bought $1,000 worth of Brainstorm Cell Therapeutics stock at the IPO in 2003 would have $-986 today, roughly -1 times their original investment - a -18.40% compound annual growth rate over 21 years.
The all-time high Brainstorm Cell Therapeutics stock closing price was 776.29 on January 07, 2005.
The Brainstorm Cell Therapeutics 52-week high stock price is 11.88, which is 586.7% above the current share price.
The Brainstorm Cell Therapeutics 52-week low stock price is 1.05, which is 39.3% below the current share price.
The average Brainstorm Cell Therapeutics stock price for the last 52 weeks is 4.45.
An investor who bought $1,000 worth of Brainstorm Cell Therapeutics stock at the IPO in 2003 would have $-986 today, roughly -1 times their original investment - a -18.40% compound annual growth rate over 21 years.
The all-time high Brainstorm Cell Therapeutics stock closing price was 776.29 on January 07, 2005.
The Brainstorm Cell Therapeutics 52-week high stock price is 11.88, which is 586.7% above the current share price.
The Brainstorm Cell Therapeutics 52-week low stock price is 1.05, which is 39.3% below the current share price.
The average Brainstorm Cell Therapeutics stock price for the last 52 weeks is 4.45.